Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRSP

CRISPR Therapeutics AG

Jun 10 • 02:47PM ET

49.72

-1.76 -3.42 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: BEAM NTLA EDIT BMRN INCY VIR ALNY IONS VRTX JAN

| Held by: ARKK IWM ARKG XBI VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.16%	Shs Outstand	96.39M	Perf Week	-4.53%
Market Cap	4.80B	Forward P/E	-	EPS next Y	-3.61	Insider Trans	-3.26%	Shs Float	89.54M	Perf Month	-7.94%
Enterprise Value	3.14B	PEG	-	EPS next Q	-1.20	Inst Own	72.72%	Short Float	24.20%	Perf Quarter	-0.42%
Income	-568.53M	P/S	1169.62	EPS this Y	24.83%	Inst Trans	0.80%	Short Ratio	11.11	Perf Half Y	-13.32%
Sales	4.10M	P/B	2.64	EPS next Y	25.73%	ROA	-23.24%	Short Interest	21.67M	Perf YTD	-5.19%
Book/sh	18.83	P/C	1.96	EPS next 5Y	29.59%	ROE	-31.21%	52W High	78.48 -36.65%	Perf Year	15.79%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	39.81 24.89%	Perf 3Y	-18.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	7.28% 5.12%	Perf 5Y	-59.81%
Dividend TTM	-	EV/Sales	766.07	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	3.01	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	44.20	Recom	1.84
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	-3.84%	Beta	1.71	Target Price	82.15
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	-5.19%	Rel Volume	0.47	Prev Close	51.48
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-10.54%	Avg Volume	1.95M	Price	49.72
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	749,709	Change	-3.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)